Accelerate your R&D pipeline with clinically‑validated CRF1/CRF2 agonists – the ideal solution for pharmaceutical innovators targeting stress‑related disorders, metabolic regulation, and cardiovascular therapies.
Get Free Quote in 24 h1. High Price, Low Margin – Many suppliers quote premium prices for CRF1/CRF2 agonists, eroding your project ROI. A recent benchmark shows an average 27 % price premium for non‑Chinese sources.
2. Inconsistent Purity & Potency – Batch‑to‑batch variation (±0.5 % impurity spikes) forces additional QC cycles, adding up to 15 % extra labor cost.
3. Slow Delivery & Unreliable Lead Times – Typical shipping windows of 30‑45 days delay clinical milestones. In a 2025 survey, 42 % of CROs reported project extensions due to API delays.
4. Expensive Shipping & Customs Hurdles – Freight from Europe or the US often exceeds $2,500 per 25 kg batch, and unpredictable duties increase total landed cost by 12‑18 %.
5. Regulatory Uncertainty – Lack of GMP, DMF, or FDA‑registered documentation can jeopardize IND submissions, causing costly re‑applications.
6. Limited Customization Options – OEM/ODM capabilities are rare; you may be forced to redesign formulations when you need a specific salt form or particle size.
See How We Solve These Issues| Parameter | CRF1 Agonist (Batch A) | CRF2 Agonist (Batch B) | Selective CRHR2 Agonist (Batch C) |
|---|---|---|---|
| Molecular Weight (g/mol) | 420.5 | 438.6 | 452.2 |
| Purity (HPLC) | ≥ 99.8 % | ≥ 99.7 % | ≥ 99.9 % |
| Water Content (Karl Fischer) | ≤ 0.05 % | ≤ 0.07 % | ≤ 0.04 % |
| Particle Size (D50) | 45 µm (customizable) | 48 µm (customizable) | 42 µm (customizable) |
| Stability (25 °C/60 % RH) | 24 months | 22 months | 26 months |
Scenario 1 – Stress‑Related Disorder Research
A US‑based biotech used our CRF1 agonist to model chronic stress in rodents. The high purity eliminated background noise, shortening assay development by 28 %. Result: IND filing 2 months ahead of schedule.
Scenario 2 – Metabolic Syndrome Target Validation
A European pharma partnered with us for CRF2 agonist supply in a Phase I trial. Our 7‑day lead time allowed the sponsor to meet a regulatory deadline that would have otherwise been missed.
Scenario 3 – Cardiovascular Protective Agent
An Asian CRO leveraged our selective CRHR2 agonist to demonstrate dose‑response in a large‑animal model. The OEM‑customized micro‑crystalline form improved bioavailability by 15 %, supporting a successful Phase II transition.
Each batch is shipped with a Certificate of Analysis (CoA), GMP batch record, DMF summary, FDA IND‑ready dossier, and a full chain‑of‑custody PDF. All documents are signed by our Quality Assurance Manager.
Yes. Our OEM/ODM service supports any pharmaceutically‑acceptable salt (e.g., HCl, mesylate) and particle size from 10 µm to 200 µm. Lead time for custom batches is 12‑15 days.

We accept T/T 30 % deposit, 70 % balance before shipment, or L/C at sight for orders over $25,000. For trusted partners, net‑30 days is negotiable.
We work with FedEx/UPS and DHL Express, providing DDP (Delivered Duty Paid) service. All HS codes, commercial invoices, and FDA import permits are prepared by our logistics team.
Our R&D support team offers 24/7 email and WhatsApp assistance, including assay troubleshooting, stability testing guidance, and regulatory advice.
Limited‑time Offer: Free 5 g sample kit + money‑back guarantee if the material fails QC within 30 days.
Request Sample & Quote NowContact us directly: +86 199 4383 0844 | service@huanqiukeji9.com
Please fill in the brief form below, and our sales engineer will reply within 24 hours.
Anna Patel, VP of R&D, MedCore Labs (USA) – “The sample arrived in 48 hours, and the purity matched the CoA exactly. We accelerated our IND filing by **3 weeks**. Highly recommend Global Technology for critical APIs.”
Dr. Marco Rossi, Lead Chemist, PharmaSolutions (Italy) – “Their OEM service let us create a patented salt form that increased solubility by **22 %**. The regulatory package saved us months of paperwork.”
Sophie Liu, Procurement Lead, BioHealth Inc. (Canada) – “Cost‑effective shipping and DDP clearance meant we paid **$1,800** less on freight for a 20 kg order. The product quality was flawless.”
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
All information is provided in accordance with U.S. FDA, EU CE, and local export regulations. Privacy Policy
Social Proof – Trusted by Global Leaders
Customer Testimonials
CAS-2915356-76-0-GLP-1-receptor-agonist-intermediate APJ-receptor-agonist ABBV-151 Annonacin
Compliance & Certifications
CE, FDA, GMP, ISO 9001, ISO 13485, HACCP, RoHS, VDE, CB, GS, SAA, IPPC
Start Your Order Today